Loading
Sydney radiation oncologist who is President of TROG Cancer Research, Australasia's radiation oncology trials group.
Purnima Sundaresan is President of the Board of TROG Cancer Research (Trans Tasman Radiation Oncology Group), the cooperative group that designs and runs radiotherapy clinical trials across Australia and New Zealand. A radiation oncologist and professor in Sydney, her research interests include clinical trials and health services research in radiation oncology. Her role is listed on TROG's board page.
| Title | Journal | Year |
|---|---|---|
| Adapting to a global pandemic through live virtual delivery of a cancer collaborative trial group conference: The TROG 2020 experience | Journal of Medical Imaging and Radiation Oncology | 2020 |
| A review of the barriers to using Patient‐Reported Outcomes (PROs) and Patient‐Reported Outcome Measures (PROMs) in routine cancer care | Journal of Medical Radiation Sciences | 2020 |
| Characteristics of chief investigators and principal investigators in Australian and New Zealand radiation oncology clinical trials | Journal of Medical Imaging and Radiation Oncology | 2023 |
Shares TROG Cancer Research and the tags leadership, clinician-scientist, radiotherapy.
Shares the tags leadership, clinician-scientist, clinical trials.
Shares the tags leadership, clinician-scientist, radiotherapy.
Shares the tags leadership, clinician-scientist, radiotherapy.
Shares the tags leadership, clinician-scientist, radiotherapy.
Shares the tags leadership, clinician-scientist, radiotherapy.
Shares the tags leadership, clinician-scientist, clinical trials.
Shares the tags leadership, clinician-scientist, clinical trials.